GlassScriptPhysician profile
Edythe B Park
NPI 1073699120
$602.77
in general payments reported to CMS, 2019-2025
15 companies · $113 in 2025
The $113 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19.24 · 2020: $44.94 · 2021: $13.46 · 2022: $34.04 · 2023: $94.01 · 2024: $284 · 2025: $113.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $491.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $491.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $119.36 | 2021-2025 | Gardasil 9, Vaxelis, Vaxneuvance |
| Astrazeneca Pharmaceuticals LP | $112.58 | 2023-2024 | Flumist Quadrivalent |
| Corium, LLC | $72.39 | 2023-2024 | Azstarys |
| Verrica Pharmaceuticals INC. | $48.07 | 2024 | Ycanth |
| Glaxosmithkline, LLC. | $38.93 | 2020-2022 | |
| Seqirus USA INC | $32.90 | 2023-2025 | Flucelvax, Flucelvax Quadrivalent |
| Cranial Technologies, INC | $29.03 | 2020-2025 | Doc Band |
| Tris Pharma INC | $23.98 | 2024 | Dyanavel Xr |
| Collegium Pharmaceutical, INC. | $22.99 | 2025 | Jornay Pm |
| Ironwood Pharmaceuticals, INC | $21.43 | 2024 | |
| Genentech USA, INC. | $19.24 | 2019 | |
| Ironshore Pharmaceuticals INC. | $18.46 | 2024 | |
| Neos Therapeutics, LP | $16.93 | 2024 | Cotempla Xr-Odt |
| Aytu Biopharma, INC. | $14.32 | 2024 | Karbinal |
| Adlon Therapeutics L.P. | $12.16 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edythe Park listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.